148 related articles for article (PubMed ID: 15576199)
1. Rationale for the development of immunotherapy regimens against enterococcal infections.
Theilacker C; Krueger WA; Kropec A; Huebner J
Vaccine; 2004 Dec; 22 Suppl 1():S31-8. PubMed ID: 15576199
[TBL] [Abstract][Full Text] [Related]
2. Enterococcal infections: host response, therapeutic, and prophylactic possibilities.
Koch S; Hufnagel M; Theilacker C; Huebner J
Vaccine; 2004 Feb; 22(7):822-30. PubMed ID: 15040934
[TBL] [Abstract][Full Text] [Related]
3. Conjugation of Different Immunogenic Enterococcal Vaccine Target Antigens Leads to Extended Strain Coverage.
Romero-Saavedra F; Laverde D; Kalfopoulou E; Martini C; Torelli R; Martinez-Matamoros D; Sanguinetti M; Huebner J
J Infect Dis; 2019 Oct; 220(10):1589-1598. PubMed ID: 31289829
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the specific immune response against capsular polysaccharides of two patients with systemic enterococcal infections.
Hufnagel M; Huebner J
Infection; 2005 Oct; 33(5-6):373-6. PubMed ID: 16258870
[TBL] [Abstract][Full Text] [Related]
5. Advances and Prospects in Vaccine Development against Enterococci.
Kalfopoulou E; Huebner J
Cells; 2020 Nov; 9(11):. PubMed ID: 33147722
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Two Metal Binding Lipoproteins as Vaccine Candidates for Enterococcal Infections.
Romero-Saavedra F; Laverde D; Budin-Verneuil A; Muller C; Bernay B; Benachour A; Hartke A; Huebner J
PLoS One; 2015; 10(8):e0136625. PubMed ID: 26322633
[TBL] [Abstract][Full Text] [Related]
7. A Vaccine Approach for the Prevention of Infections by Multidrug-resistant Enterococcus faecium.
Kodali S; Vinogradov E; Lin F; Khoury N; Hao L; Pavliak V; Jones CH; Laverde D; Huebner J; Jansen KU; Anderson AS; Donald RG
J Biol Chem; 2015 Aug; 290(32):19512-26. PubMed ID: 26109072
[TBL] [Abstract][Full Text] [Related]
8. Treatment and prevention of enterococcal infections--alternative and experimental approaches.
Koch S; Hufnagel M; Huebner J
Expert Opin Biol Ther; 2004 Sep; 4(9):1519-31. PubMed ID: 15335318
[TBL] [Abstract][Full Text] [Related]
9. Formation of vegetations during infective endocarditis excludes binding of bacterial-specific host antibodies to Enterococcus faecalis.
McCormick JK; Tripp TJ; Dunny GM; Schlievert PM
J Infect Dis; 2002 Apr; 185(7):994-7. PubMed ID: 11920326
[TBL] [Abstract][Full Text] [Related]
10. Conjugate vaccines against group B Streptococcus types IV and VII.
Paoletti LC; Kasper DL
J Infect Dis; 2002 Jul; 186(1):123-6. PubMed ID: 12089673
[TBL] [Abstract][Full Text] [Related]
11. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
[TBL] [Abstract][Full Text] [Related]
12. Opsonic antibodies to Enterococcus faecalis strain 12030 are directed against lipoteichoic acid.
Theilacker C; Kaczynski Z; Kropec A; Fabretti F; Sange T; Holst O; Huebner J
Infect Immun; 2006 Oct; 74(10):5703-12. PubMed ID: 16988246
[TBL] [Abstract][Full Text] [Related]
13. Application of vaccine technology to prevention of Pseudomonas aeruginosa infections.
Pier G
Expert Rev Vaccines; 2005 Oct; 4(5):645-56. PubMed ID: 16221066
[TBL] [Abstract][Full Text] [Related]
14. Optimizing therapy for vancomycin-resistant enterococci (VRE).
Linden PK
Semin Respir Crit Care Med; 2007 Dec; 28(6):632-45. PubMed ID: 18095227
[TBL] [Abstract][Full Text] [Related]
15. E. faecalis vancomycin-sensitive enterococcal bacteremia unresponsive to a vancomycin tolerant strain successfully treated with high-dose daptomycin.
Cunha BA; Mickail N; Eisenstein L
Heart Lung; 2007; 36(6):456-61. PubMed ID: 18005808
[TBL] [Abstract][Full Text] [Related]
16. Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin Outcomes Registry and Experience (CORE).
Mohr JF; Friedrich LV; Yankelev S; Lamp KC
Int J Antimicrob Agents; 2009 Jun; 33(6):543-8. PubMed ID: 19201165
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic and therapeutic efficacy of antibodies to a capsular polysaccharide shared among vancomycin-sensitive and -resistant enterococci.
Huebner J; Quaas A; Krueger WA; Goldmann DA; Pier GB
Infect Immun; 2000 Aug; 68(8):4631-6. PubMed ID: 10899866
[TBL] [Abstract][Full Text] [Related]
18. Synthetic teichoic acid conjugate vaccine against nosocomial Gram-positive bacteria.
Laverde D; Wobser D; Romero-Saavedra F; Hogendorf W; van der Marel G; Berthold M; Kropec A; Codee J; Huebner J
PLoS One; 2014; 9(10):e110953. PubMed ID: 25333799
[TBL] [Abstract][Full Text] [Related]
19. Detection and characterization of bacterial polysaccharides in drug-resistant enterococci.
Ali L; Blum HE; Sakιnç T
Glycoconj J; 2019 Oct; 36(5):429-438. PubMed ID: 31230165
[TBL] [Abstract][Full Text] [Related]
20. Molecular Cloning and Immunogenicity Evaluation of PpiC, GelE, and VS87_01105 Proteins of Enterococcus faecalis as Vaccine Candidates.
Kazemian H; Pourmand MR; Siadat SD; Mahdavi M; Yazdi MH; Avakh Majelan P; Afshar D; Yaseri M; Davari M; Ibrahim Getso M
Iran Biomed J; 2019 Sep; 23(5):344-53. PubMed ID: 31103023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
